Hypothyroidism, drug reimbursement

HYPOTHY_REIMB

hypothyroidism: Abnormally low levels of thyroid hormone.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

KELA reimbursements: KELA codes 104

1 out of 7 registries used, show all original rules.

12417

diagram downward connector

Check minimum number of events None

12417

diagram downward connector

Include endpoints None

12417

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

12040

diagram downward connector
HYPOTHY_REIMB

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
Number of individuals 12040 9977 2063
Unadjusted prevalence (%) 3.19 4.73 1.24
Mean age at first event (years) 46.84 45.95 51.17

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.41 [1.16, 1.70] 4.8e-4 1192
15 years 0.01 1.01 [0.86, 1.18] 9.2e-1 520
5 years 0.00 1.00 [0.82, 1.22] 9.7e-1 137
1 year 0.00 1.33 [0.92, 1.93] 1.3e-1 32

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: HYPOTHY_REIMB – Hypothyroidism, drug reimbursement
GWS hits: 23

Survival analyses between endpoints

Plot

before Hypothyroidism, drug reimbursement
after Hypothyroidism, drug reimbursement

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Hypothyroidism, drug reimbursement

Endpoint not on priority list, no data to show.